EU Regulators Clarify How ‘Super-Grouping’ Under New Variations Rules Will Work

New guidance explains requirements related to making changes to drugs approvals • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Post-Marketing Regulation & Studies

More from Product Reviews